论文部分内容阅读
目的:寻找康莱特联合化疗药物健择和顺铂的最佳时机。方法:采用MTT比色的方法。结果:康莱特对人肺腺癌95D的生长有抑制作用和化疗增敏作用;康莱特先于健择,顺铂加入对95D的抑制最强。结论:康莱特先于健择或顺铂加入优于两药同时加入。
Objective: To find the best time to combine Kanglaite with chemotherapy and cisplatin. Methods: MTT colorimetric method. RESULTS: Kanglaite had inhibitory effect on the growth of human lung adenocarcinoma 95D and chemosensitivity. Kanglaite had the strongest inhibition on 95D when treated with Gemcitabine and cisplatin. CONCLUSION: Kanglaite was better than Gemcitabine or cisplatin before the two drugs were added simultaneously.